Getz Pharma started marketing products in Sudan in 2008, With a strong marketing strategy, well-educated and highly trained team and patient centric approach, Getz Pharma has achieved rapid growth in Sudan.
In Sudan, Getz Pharma products span the following therapeutic segments:
Getz Pharma pioneered Pregabalin (Gabica) and Rosuvastatin (Rovista) in Sudan, and is a market leader in these segments. Similarly, Glimepiride (Getryl), Montelukast (Montiget) and Hydroxychloroquine (HCQ) are also market leaders in their respective fields.
You are about to be redirected to an online retailer’s website. Getz Pharma is not liable for any data exchange on the new website
You will be redirected in 3secs
Disclaimer: "This message (including attachment) is intended solely for the use of the individual or entity whom it is addressed and may contain information that is confidential or privileged. If you are not the intended recipient of this message, you are hereby notified that any use, dissemination, distribution or reproduction of this message is prohibited and that, you must not take any action in reliance on it. E-mail transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrived incomplete or contain viruses; therefore Getz Pharma (Private) Limited cannot accept legal responsibility for the contents of this message. If you have received this communication in error, please notify the sender or Getz Pharma (Private) Limited at [email protected] immediately and destroy the original message."Close